News

By Priscila Mayumi Kashiwabara

4 de August de 2023

Cannabis and IP: Nurturing innovation in Brazil’s Life Sciences industry

Check out the article “Cannabis and IP: Nurturing innovation in Brazil’s life sciences industry”, authored by Priscila Kashiwabara and Luan Scalzitti and published in Life Sciences Intellectual Property Review (LSIPR).

Providing an insightful overview of the cannabis industry’s rapid growth and the increasing need for tailored intellectual property (IP) protection, the article highlights the significance of medical cannabis, which possesses valuable pharmaceutical properties and is gaining legal recognition globally, thereby driving industry expansion.

The rising number of patent applications related to cannabis, especially in Brazil following regulatory changes, demands new approaches to navigate the evolving legal landscape in the cannabis industry. And we can help you with these.

Click here to read full article.

Back

Last by Priscila Mayumi Kashiwabara

25 de August de 2026

Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project

On August 25, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of a Collaborative Patent Application Examination Project in … Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project

Ler notícia

14 de August de 2026

INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology

On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed … INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology

Ler notícia

1 de July de 2026

INPI Ordinance No. 80/2026 and Second Medical Use Patents

INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents

Ler notícia